US Earnings Financial Results SEC Filings — August 18, 2026

18-08-2026

IRIDEX CORP reported a net loss of $1.266M for Q2 FY26 (three months ended July 4, 2026), compared to a net loss of $0.994M in the same quarter last year, with total revenues declining 7.4% YoY to $12.566M. For the six-month period, net loss improved to $1.790M from $2.680M in the prior year, driven by a significant reduction in other expenses. However, gross profit margin contracted slightly, and cash and cash equivalents decreased by $1.348M to $4.680M.

• · Operating expenses decreased 5.3% YoY in Q2 FY26 to $5.325M, driven by a 16.9% reduction in general and administrative expenses.
• · Research and development expenses increased 7.5% YoY in Q2 FY26 to $0.936M.
• · Sales and marketing expenses remained nearly flat at $2.547M in Q2 FY26 vs $2.535M in Q2 FY25.
• · Net cash used in operating activities improved to $1.161M in H1 FY26 from $1.546M in H1 FY25.
• · Inventories increased 23.8% from $7.877M (Jan 3, 2026) to $9.752M (July 4, 2026).
• · Accounts receivable decreased 25.5% from $7.613M to $5.674M over the same period.
• · The company had a convertible note payable of $3.795M as of July 4, 2026, up slightly from $3.735M at January 3, 2026.
• · Deferred revenue (current + non-current) totaled $8.224M as of July 4, 2026, down from $9.856M a year earlier.

18-08-2026

Cannapharmarx, Inc. reported results for its fiscal Q2 and first half of 2026, with revenue increasing to $276,218 for the quarter ended June 30, 2026, up 19.3% from $231,608 in the same period last year. The company narrowed its gross loss significantly to $138,446 from a gross loss of $621,210 in Q2 2025. However, the net loss widened to $1,909,042 from $1,413,458 year-over-year, driven by large non‑cash charges related to derivative conversions and imputed interest expenses. The company remains in a deeply negative equity position, with total shareholders' deficit of $30,830,561 at June 30, 2026.

• · Cash at June 30, 2026 was only $555, down from $1,804 at year-end 2025.
• · Total current liabilities of $32,569,584 far exceed total assets of $6,891,942, resulting in a working capital deficit of $31,236,572.
• · Gross loss for Q2 2026 improved to $138,446 from $621,210 in Q2 2025, a 77.8% reduction.
• · Operating expenses increased 9.4% YoY in Q2 2026 to $240,385 from $219,770.
• · Total shareholders' deficit increased to $30,830,561 at June 30, 2026 from $30,153,729 at December 31, 2025.
• · The company had a stock-based non-cash charge from derivative conversion feature of $1,599,738 in Q2 2026 vs $46,438 in Q2 2025.
• · Inventory increased 17.1% to $1,306,302 at June 30, 2026 from $1,115,322 at December 31, 2025.
• · Accounts receivable declined drastically to $6,811 at June 30, 2026 from $164,430 at December 31, 2025.
• · Net cash used in operating activities for H1 2026 was $371,025 vs $1,047,844 in H1 2025, an improvement of $676,819.
• · Financing activities provided $424,894 from related party loans in H1 2026.
• · Loss per share remained at $0.00 for all periods presented.
• · Weighted average shares outstanding increased to 682,482,306 in Q2 2026 from 662,501,405 in Q2 2025.
• · Impairment of work in process inventory totaled $530,672 at June 30, 2026 vs $486,480 at December 31, 2025.
• · Additional impairment of finished goods inventory of $159,038 was recognized in Q2 2026, bringing total inventory impairment to $689,710 (included in cost of goods sold).

18-08-2026

Boost Run Inc. (BRUN) reported a net loss of $75.0M for Q2 2026 vs. net income of $2.5M in Q2 2025, driven by a $55.7M deferred tax provision and a surge in operating expenses. Revenue grew 270% YoY to $31.1M, but the company swung to an operating loss of $12.9M from a $3.0M profit. The balance sheet expanded dramatically to $742.3M in total assets, fueled by a business combination and warrant exercises, while accumulated deficit grew to $96.2M.

• · Selling, general and administrative expenses surged to $13.6M in Q2 2026 from $0.8M in Q2 2025, a 1,618% increase.
• · Depreciation and amortization rose to $18.1M in Q2 2026 from $2.5M in Q2 2025.
• · A $55.7M deferred tax liability was recorded in Q2 2026, contributing significantly to the net loss.
• · The company issued 44,150,000 shares of common stock valued at $441,500 in connection with the business combination.
• · Operating cash flow was positive at $114.2M for H1 2026 vs. $8.6M in H1 2025, driven by a $112.9M increase in customer deposits.
• · Capital expenditures (purchases of equipment) were $29.6M in H1 2026 vs. $2.9M in H1 2025.
• · Finance lease payments totaled $99.9M in H1 2026 vs. $5.5M in H1 2025.
• · The company had no debt (current or non-current) as of June 30, 2026, compared to $4.8M total debt at December 31, 2025.
• · Basic and diluted loss per share for Class A and Class B was $(1.67) for Q2 2026 and $(2.09) for H1 2026.
• · Weighted-average diluted shares outstanding increased to 45.0M in Q2 2026 from 42.1M in Q2 2025.

18-08-2026

Polar Power, Inc. reported a net loss of $1.8M for Q2 2026, a significant deterioration from a $0.3M loss in Q2 2025, driven by a 62% decline in net sales to $1.0M. While operating expenses decreased 22% year-over-year, gross profit swung from a $0.9M profit to a $0.3M loss, and the company's cash position remains precarious at $0.2M. The company raised $2.4M through an ATM facility and $1.1M in convertible notes during the first half of 2026, but operating cash flow worsened to -$2.2M.

• · DC power systems sales fell 62% to $0.7M in Q2 2026 from $2.0M in Q2 2025.
• · Engineering & Tech Support Services revenue dropped 84% to $21K in Q2 2026 from $135K in Q2 2025.
• · Accessories sales declined 57% to $0.3M in Q2 2026 from $0.6M in Q2 2025.
• · Interest expense and finance costs increased 161% to $0.4M in Q2 2026 from $0.2M in Q2 2025.
• · The company recorded a $0.3M non-cash gain from change in derivative liability valuation in Q2 2026.
• · Inventories remained high at $9.2M, representing over 9 quarters of current sales run-rate.
• · Accounts receivable increased 72% to $0.6M from $0.3M at year-end 2025.
• · The company had a line of credit balance of $2.7M at June 30, 2026, down from $4.0M at December 31, 2025.
• · Convertible notes payable, net of discount, stood at $0.2M at June 30, 2026 (none at year-end 2025).
• · Derivative liabilities of $0.8M were recognized at June 30, 2026 (none at year-end 2025).
• · Operating lease liabilities decreased 84% to $0.1M from $0.5M at year-end 2025.
• · Net loss per share (basic and diluted) was -$0.49 for Q2 2026 vs -$0.11 for Q2 2025.
• · Weighted average shares outstanding increased 48% to 3.7M in Q2 2026 from 2.5M in Q2 2025.

18-08-2026

Mercury Systems Inc. reported fiscal 2026 annual results with net revenues of $983.6M, up 7.9% from $912.0M in fiscal 2025, and a narrowed net loss of $(29.7M) compared to $(37.9M) in the prior year. The company achieved a positive operating income of $0.3M versus an operating loss of $(19.6M) in fiscal 2025, and Adjusted EBITDA grew 25.8% to $150.2M. However, cash flow from operations declined to $102.4M from $138.9M, and free cash flow fell to $68.1M from $119.0M, while the company ended the year with $214.3M in cash, down from $309.1M.

• · Research and development expense decreased 11.7% to $59.7M in fiscal 2026 from $67.6M in fiscal 2025.
• · Selling, general and administrative expense increased 13.3% to $175.0M from $154.4M.
• · Interest expense decreased 11.5% to $29.6M from $33.4M.
• · Stock-based compensation expense increased 49.3% to $57.1M from $38.3M.
• · The company retired 222 thousand shares of common stock for $15.0M during fiscal 2026.
• · Accounts receivable decreased 36.8% to $69.2M from $109.6M.
• · Inventory increased 10.2% to $367.0M from $332.9M.
• · Goodwill remained relatively flat at $942.4M vs $938.1M.
• · Deferred revenues and customer advances increased 17.9% to $149.6M from $126.8M.
• · The company had a net loss per share of $(0.50) in fiscal 2026, improved from $(0.65) in fiscal 2025.
• · Adjusted diluted earnings per share was $1.06 in fiscal 2026, up from $0.64 in fiscal 2025.

18-08-2026

Nukkleus Inc. (NUKKW) reported its financial results for the six and three months ended June 30, 2026, showing a significant shift from profitability to deep loss compared to the prior year period. For the six months ending June 30, 2026, the company recorded a net loss attributable to stockholders of $109,634M, compared to net income of $105,977M in the same 2025 period. This swing was primarily driven by a massive $107,641M non-cash charge from changes in the fair value of stock purchase warrant liabilities, which added a volatile element to overall performance.

• · The company's accumulated deficit deepened from $122,527M at December 31, 2025 to $232,162M at June 30, 2026.
• · Goodwill increased from $7,688M to $99,047M, indicating significant acquisition activity.
• · Stock purchase warrant liabilities surged from $24,521M to $124,387M during the period.
• · Cash used in operating activities for continuing operations was $9,895M in H1 2026 versus $2,981M in H1 2025.
• · Cash flow from financing activities provided $15,353M in H1 2026, compared to a use of $878M in H1 2025.
• · Common shares outstanding increased from 152,206 at year-end 2025 to 758,660 at June 30, 2026.
• · The company incurred a loss on marketable securities of $3,705M in H1 2026.
• · Net cash used in investing activities was $4,443M in H1 2026, mainly for acquisitions.

18-08-2026

Columbus Circle Capital Corp III (CCCT) filed its Form 10-Q for the quarterly period ended June 30, 2026, reporting a net loss of $74,606 for both the three and six months ended June 30, 2026, compared to no prior period results as the company was pre-IPO. Total assets increased to $203,942 from $44,281 at December 31, 2025, primarily due to deferred offering costs of $201,690, while total current liabilities rose to $259,267 from $25,000, driven by the IPO Promissory Note balance of $239,922. The company's accumulated deficit widened to ($80,325) from ($5,719), resulting in a shareholders' deficit of ($55,325) compared to positive equity of $19,281 at year-end 2025.

• · The company had no cash at both June 30, 2026 and December 31, 2025.
• · Net cash used in operating activities was $0 for the six months ended June 30, 2026.
• · General and administrative costs of $74,606 were incurred entirely in the three and six months ended June 30, 2026, with $59,606 paid through the IPO Promissory Note.
• · Deferred offering costs of $153,064 were paid through the IPO Promissory Note, and $10,225 through prepaid expenses.
• · The IPO Registration Statement on Form S-1 was declared effective on July 8, 2026 (File No. 333-296208).
• · The company has a Nasdaq 36-Month Requirement to complete a business combination within 36 months following the effectiveness of its IPO registration statement.
• · No Class A ordinary shares were issued or outstanding as of June 30, 2026.
• · Basic and diluted net loss per Class B ordinary share was ($0.01) for both the three and six months ended June 30, 2026.

18-08-2026

Outlook Therapeutics reported a net loss of $20.3M for Q3 FY2026 (three months ended June 30, 2026), slightly wider than the $20.2M loss in the same quarter last year. For the nine-month period, net loss narrowed to $47.8M from $49.1M year-over-year. The company generated minimal product revenue of $8,700 in Q3 FY2026, a sharp decline from $1.5M in Q3 FY2025, and recorded a negative gross profit. However, operating expenses were reduced significantly, with R&D down 54% and SG&A down 22% in the quarter. Cash and cash equivalents increased to $11.2M from $8.1M at September 30, 2025, supported by $49.0M in net financing activities, though the company continues to operate with a stockholders' deficit of $10.4M.

• · Revenue for the nine months ended June 30, 2026 was negative $1.1M, reflecting sales returns exceeding gross sales.
• · Gross profit was negative $8,265 in Q3 FY2026 and negative $1.3M for the nine-month period.
• · The company recorded a $7.0M loss from change in fair value of warrant liability in Q3 FY2026, compared to a $2.0M loss in Q3 FY2025.
• · A $1.3M loss on extinguishment of debt was recognized in Q3 FY2026.
• · Operating cash outflow was $43.8M for the nine months ended June 30, 2026, up from $39.5M in the prior period.
• · The company invested $2.1M in a joint venture during the nine-month period.
• · Total liabilities decreased from $50.8M to $36.6M, primarily due to conversion of convertible promissory notes into equity.
• · Stockholders' deficit improved from $32.2M to $10.4M, driven by equity issuances and warrant conversions.
• · The company had an accumulated deficit of $653.5M as of June 30, 2026.

18-08-2026

Crown PropTech Acquisitions (CPTKW) reported a net loss of $2.0M for the three months ended June 30, 2026, widening from $1.2M in the prior-year quarter, driven largely by a $0.995M non-cash charge from the change in fair value of warrant liabilities. Total operating costs declined slightly to $0.94M from $1.01M, but cash from operations consumed $0.96M in the first half of 2026 versus $0.27M a year earlier. The company continues to fund operations through a promissory note to related parties, and held just $425 in cash outside the trust account.

• · As of June 30, 2026, total liabilities ($7.4M) exceeded total assets ($5.8M), resulting in a shareholders' deficit of $7.3M.
• · The company had no Class A ordinary shares issued outside those subject to possible redemption; all 6.9M Class B shares were held by the sponsor.
• · Warrant liabilities of $1.0M were recorded for the first time at June 30, 2026.
• · The Trust Account balance of $5.8M is entirely attributable to redeemable Class A shares with a redemption value of $11.98 per share.

18-08-2026

MOBIX LABS, INC. reported a net loss of $16.8M for Q3 FY26 (three months ended June 30, 2026), nearly doubling from the $8.3M loss in the prior-year quarter, as total net revenue plunged 66% to $0.8M from $2.4M. While operating expenses were reduced 9% YoY, gross profit collapsed 92% to $0.1M, and the company posted a negative stockholders' equity of $6.2M (improved from -$0.3M at Sep 25 after raising fresh capital). For the nine-month period, the net loss widened to $32.8M (vs. $30.4M a year ago), and cash used in operations increased sharply to $14.7M from $5.6M.

• · Product revenue fell 65% YoY to $0.5M in Q3 FY26; service revenue dropped 69% to $0.3M.
• · Operating expenses were reduced 9% YoY in Q3, yet still exceeded gross profit by a factor of 72x.
• · Selling, general and administrative expenses remained the largest cost at $21.9M for the nine-month period.
• · A $3.7M loss on issuance of preferred shares and liability-classified warrants was recorded in Q3 FY26.
• · Notes payable measured at fair value, current, of $3.4M appeared as a new liability item in Q3 FY26.
• · The company raised $5.4M from a public offering of common stock during Q2 FY26.
• · Total liabilities decreased 29% to $26.7M as of June 30, 2026 (from $37.4M at Sep 2025), primarily due to settlement of notes payable via common stock ($10.6M non-cash).
• · Cash at end of Q3 FY26 was $2.1M, down from $3.3M at Sep 2025 but up from $0.2M a year ago.

18-08-2026

CLOUDASTRUCTURE, INC. (CSAI) filed its Form 10-Q for the quarterly period ended June 30, 2026, reporting a net loss of $1.731M (improvement from a $2.186M loss in the same quarter last year) on revenues of $1.233M, up 13.5% year-over-year from $1.086M. However, operating expenses rose sharply, particularly sales & marketing (+51.6%) and operations (+109.9%), and the company's cash position declined from $8.453M to $3.807M, while key operating losses widened to $2.102M from $1.924M, indicating continued cash burn and scaling challenges.

• · Sales and marketing expenses surged 51.6% YoY to $943k in Q2 2026, while operations expenses more than doubled to $359k.
• · A material weakness in internal controls over financial reporting was identified and disclosed.
• · The company extinguished its derivative liability via an amendment on June 29, 2026, resulting in a $319k gain for Q2.
• · A new $1.3M note payable maturing July 30, 2027 was issued; temporary equity preferred stock was fully extinguished or reclassified.
• · The company has significant customer concentration risk and anticipates sustaining operating losses for the foreseeable future.
• · Cash used in operations (indicated by $4.505M net loss and declining cash) continues to consume liquidity rapidly.

18-08-2026

Churchill Capital Corp X/Cayman (CCCXU) filed its 10-Q for the quarter ended June 30, 2026, reporting total revenue of $13.5M for Q2 2026, up 157% from $5.3M in Q2 2025, driven by a surge in service revenue ($10.4M vs $1.7M). However, the company posted a net loss of $24.7M for the quarter, widening from a $9.2M loss in the prior-year period, as operating expenses (R&D and SG&A) grew faster than revenue. The balance sheet strengthened significantly following a business combination, with total assets of $641.5M (up from $113.2M at year-end 2025) and stockholders' equity of $574.4M (vs. a deficit of $210.7M).

• · Product revenue declined 11% YoY in Q2 2026 ($3.2M vs $3.6M) and 31% in H1 2026 ($6.8M vs $9.9M).
• · Service revenue surged 504% YoY in Q2 2026 ($10.4M vs $1.7M) and 361% in H1 2026 ($16.7M vs $3.6M).
• · Gross profit improved to $2.2M in Q2 2026 from $0.7M in Q2 2025, but gross margin remained low at 16%.
• · Operating expenses (R&D + SG&A) totaled $32.5M in Q2 2026, up 181% from $11.6M in Q2 2025.
• · Stock-based compensation expense was $20.4M in H1 2026 vs $1.9M in H1 2025, a 979% increase.
• · Cash used in operating activities improved to $6.0M in H1 2026 from $9.7M in H1 2025.
• · The company held $541.2M in financial assets (cash equivalents and available-for-sale securities) as of June 30, 2026.
• · All convertible redeemable preferred stock ($296.8M) was converted to common stock during H1 2026.
• · Weighted average shares outstanding increased from 15.6M in Q2 2025 to 219.7M in Q2 2026.
• · Net loss per share improved from ($0.59) in Q2 2025 to ($0.11) in Q2 2026 due to the increase in share count.

18-08-2026

Aeon Acquisition I Corp. filed its Form 10-Q for the period ended June 30, 2026, reporting net income of $268,384 for the three months and $208,319 for the six months ended June 30, 2026. The company completed its Initial Public Offering (IPO) during the period, generating gross proceeds of $143.75M and placing $144.1M in a trust account. However, the company reported a net loss per share for non-redeemable shares of ($0.01) for the quarter and ($0.02) for the six-month period, and ended the period with an accumulated deficit of $3.87M.

• · The company completed its IPO during the period, with gross proceeds of $143.75M.
• · Formation and operating costs were $104,406 for the three months and $164,471 for the six months ended June 30, 2026.
• · Interest income on cash held in trust account was $372,790 for both the three and six month periods.
• · The company had a deferred underwriting fee of $4.31M as of June 30, 2026.
• · On May 12, 2026, the Sponsor surrendered 6,160,714 founder shares for no consideration.
• · The company had an advance from a related party of $21,654 as of June 30, 2026.
• · Net cash used in operating activities was $217,339 for the six months ended June 30, 2026.
• · Net cash provided by financing activities was $144.27M for the six months ended June 30, 2026.

18-08-2026

DYNARESOURCE, INC. reported mixed results for Q2 2026. Net income attributable to common stockholders rose 28.4% YoY to $571,775 for the quarter and more than tripled to $3.0M for the six-month period. However, revenue declined 28.0% YoY in Q2 to $11.4M, and gross profit fell 81.4% to $963,442, swinging the company to an operating loss of $1.2M from a $2.7M profit a year ago. Cash decreased 57.6% from year-end to $1.8M, while total assets grew 7.2% to $61.7M, and stockholders' equity turned positive at $4.2M from a deficit of $1.1M.

• · Total liabilities decreased 2.2% from $52.8M at Dec 31, 2025 to $51.6M at June 30, 2026.
• · Accumulated deficit improved 4.8% from ($65.4M) to ($62.2M).
• · Derivative liability decreased 71.4% from $1.2M to $356,857.
• · Mine development costs (capitalized) increased 55.7% from $8.9M to $13.9M.
• · Depreciation and depletion expense more than doubled in H1 2026 to $998,024 from $408,537 in H1 2025.
• · Total tax expense decreased 12.4% in H1 2026 to $1.8M from $2.0M.
• · Foreign currency translation generated a loss of $282,638 in Q2 2026 vs a gain of $1.0M in Q2 2025.
• · Cash paid for interest increased 39.1% in H1 2026 to $645,917 from $464,459.
• · The company drew down $2.5M on its credit line in H1 2026 (net of repayments), with total credit line outstanding at $12.5M.

18-08-2026

Fabrinet (FN) filed its Form 10-K for the fiscal year ended June 26, 2026, reporting strong revenue growth of 35.7% to $4.64B and net income growth of 42.3% to $473.0M. The data center and communications infrastructure segments drove performance, with data center revenue up 40.8% to $2.23B. However, gross margin declined slightly to 12.0% from 12.1%, cash from operations fell 21.8% to $256.7M, and the Asia-Pacific revenue mix decreased.

• · Operating cash flow declined 21.8% to $256.7M despite revenue growth.
• · Capital expenditures more than doubled to $298.9M from $130.7M.
• · Short-term investments decreased to $528.3M from $627.8M.
• · Total shareholders' equity increased to $2.45B from $1.98B.
• · Income tax expense surged 262.3% to $82.1M from $22.7M.
• · The company recorded $57.0M in other income in FY2026 vs. a $0.2M loss in FY2025.
• · Revenue mix from Automotive, Industrial & Others dropped to 18.8% from 23.1%.
• · Asia-Pacific revenue contribution slipped to 73.9% from 74.3%.
• · North America revenue contribution increased to 22.7% from 21.6%.
• · Accumulated other comprehensive income turned from positive $10.3M to $1.0M.

18-08-2026

iQSTEL Inc. reported a 51% YoY revenue increase to $109.1M for Q2 2026 and $207.0M for H1 2026, driven by strong top-line growth. However, the company remained unprofitable, with a net loss attributable to IQSTEL of $2.6M in Q2 and $4.0M in H1, widening from $2.4M and $3.6M in the prior-year periods. Operating losses also increased, and cash flow from operations remained negative at -$1.7M for H1 2026.

• · Operating expenses increased 53% YoY to $3.9M in Q2 2026 and 36% to $6.9M in H1 2026.
• · Interest expense decreased 32% YoY to $313.6K in Q2 2026 and 33% to $664.6K in H1 2026.
• · Loss on settlement of debt was $926.1K in both Q2 and H1 2026, slightly higher than $878.6K in the prior year periods.
• · Cash used in operating activities was -$1.7M in H1 2026, nearly unchanged from -$1.6M in H1 2025.
• · Accounts receivable decreased $3.6M in H1 2026, compared to a $33.5M decrease in H1 2025.
• · Total liabilities decreased to $31.0M as of June 30, 2026 from $34.8M at December 31, 2025.
• · Common shares outstanding more than doubled to 10.1M from 4.7M at year-end 2025, primarily due to conversions of Series D preferred stock and issuances for financing commitments.
• · Basic and diluted loss per share improved to -$0.38 in Q2 2026 from -$0.82 in Q2 2025, and to -$0.68 from -$1.28 in H1, due to the increased share count.

18-08-2026

INNO HOLDINGS INC. reported a net loss of $1.62M for the three months ended June 30, 2026, slightly wider than the $1.55M loss in the same quarter last year. Revenue more than doubled to $2.07M from $1.09M, driven by product sales, and gross profit turned positive at $93,424 versus a negative gross profit of ($16,050) in the prior-year quarter. However, operating expenses remained high at $1.60M, and the company's accumulated deficit grew to $17.54M. Cash and cash equivalents surged to $33.24M from $10.13M at September 30, 2025, primarily due to $37.75M in proceeds from share issuances, including two reverse stock splits in December 2025 and May 2026.

• · The company completed two reverse stock splits: a 1-for-24 split on December 22, 2025, and a 1-for-20 split on May 4, 2026, reducing outstanding shares from 50,410,884 to 2,520,581.
• · Selling, general and administrative expenses for the three months ended June 30, 2026 were $1.60M, slightly up from $1.54M in the prior-year quarter.
• · Interest income increased sharply to $293,868 for the quarter (vs. $14,549 in Q3 2025), reflecting higher cash balances.
• · The company recorded a $200,000 loss on investment disposal and a $200,000 change in fair value of investment in the current quarter.
• · Net cash used in operating activities for the nine months ended June 30, 2026 was $11.63M, compared to $3.70M in the prior period, driven by increases in inventories and prepayments.
• · The company had no revenue from discontinued operations in either period.
• · Weighted average basic and diluted shares outstanding for the quarter were 2,317,314 (2026) vs. 10,738 (2025), reflecting the reverse stock splits and new issuances.
• · Loss per share improved dramatically from ($144.00) to ($0.70) for the quarter due to the increased share count.

18-08-2026

Axil Brands, Inc. (AXIL) filed its 10-K annual report for the fiscal year ended May 31, 2026, reporting strong financial performance. Revenue grew 17.5% to $30.85M, and net income surged 215.7% to $2.70M, driven by a 159% increase in retail and wholesale revenue in the hearing enhancement segment. However, the company's direct-to-consumer channel declined 4.3% year-over-year, and operating cash flow turned negative at -$9,635 compared to positive $1.93M in the prior year.

• · Operating cash flow turned negative to -$9,635 in FY 2026 from positive $1.93M in FY 2025.
• · Cash and cash equivalents decreased 6.5% to $4.46M from $4.77M.
• · Hair and skin care segment revenue declined 21.9% to $1.19M.
• · Direct-to-consumer revenue in the hearing enhancement segment declined 4.3% to $19.70M.
• · Total liabilities increased 50.0% to $4.81M from $3.21M.
• · Accounts receivable surged 373% to $4.75M from $1.00M.
• · Inventory increased 74.4% to $4.42M from $2.53M.
• · The company initiated a new marketing services revenue channel generating $100,000 in FY 2026.
• · Stock-based compensation decreased to $785,160 from $1,108,934.

18-08-2026

La-Z-Boy Incorporated reported a net loss of $2.3M for the quarter ended July 25, 2026, compared to net income of $18.2M in the same quarter last year, driven by a 3.4% decline in sales to $475.7M and a significant increase in SG&A expenses. The company also saw operating income swing to a loss of $2.1M from a profit of $22.0M, while cash flow from operations halved to $15.6M. However, the company continued share repurchases ($25.1M) and dividends ($9.7M), and total assets remained solid at $2.0B.

• · Gross profit margin was essentially flat at 43.9% vs. 42.5% in the prior year quarter.
• · SG&A expense increased 12.6% YoY, outpacing the sales decline and driving the operating loss.
• · The company recorded a $4.7M lease impairment charge in the quarter.
• · Capital expenditures increased to $23.3M from $18.5M in the prior year quarter.
• · The company spent $15.7M on acquisitions during the quarter, compared to $0.6M a year ago.
• · Total shareholders' equity decreased to $1.03B from $1.06B at the end of the prior fiscal year.
• · The company adopted ASU 2025-05 (credit losses) and ASU 2024-04 (convertible debt) in fiscal 2027.

18-08-2026

CIRTRAN CORP (CIRX) filed its 10-Q for the quarter ended June 30, 2026, reporting a dramatic improvement in net sales, which surged 595% YoY to $1.17M in Q2 2026 and 271% to $2.33M in the first half. The company swung to operating income of $160,628 in Q2 2026 from a loss of $(193,258) in Q2 2025. However, the company remains deeply insolvent with a stockholders' deficit of $(22.99M) and total liabilities of $25.60M, though the deficit narrowed from $(25.11M) at year-end 2025. Net income for the six-month period was $2.11M, driven by a $2.27M gain from discontinued operations, while continuing operations still posted a net loss of $(161,254).

• · Inventory decreased from $1,136,546 (Dec 31, 2025) to $1,032,170 (June 30, 2026), a decline of 9.2%.
• · Accounts receivable increased 31.3% from $365,661 to $480,118.
• · Liabilities for product returns and credits fell 43.2% from $90,810 to $51,551.
• · Accrued liabilities decreased 4.3% from $2,758,884 to $2,640,845.
• · Derivative liabilities decreased 2.6% from $2,393,544 to $2,330,519.
• · Liabilities from discontinued operations dropped 47.2% from $4,818,427 to $2,544,396.
• · Accrued interest (current portion) rose 4.6% from $6,739,423 to $7,048,884.
• · Accrued payroll and compensation expense increased 1.9% from $5,674,164 to $5,784,805.
• · Net cash provided by operating activities was $124,586 in H1 2026 vs. $(627,088) used in H1 2025.
• · No cash paid for interest or income taxes in either period.
• · The company has no revenue from discontinued operations but recorded a $2.27M gain in H1 2026.
• · Basic and diluted weighted average shares outstanding remained constant at 4,945,417.

18-08-2026

Cosmos Health Inc. reported revenue growth of 29.7% YoY to $18.99M for Q2 2026 and 29.7% YoY to $36.91M for H1 2026, driven by strong operational performance. However, net loss widened significantly to $6.09M in Q2 2026 (up 115.2% YoY) and $8.89M in H1 2026 (up 143.9% YoY), primarily due to non-cash charges including a $2.38M change in fair value of convertible notes and a $0.40M loss on digital assets. Cash and restricted cash increased to $2.45M from $0.66M a year ago, but operating cash flow remained negative at -$2.79M for H1 2026.

• · Inventory decreased 21.8% to $4.52M from $5.78M at Dec 31, 2025.
• · Accounts receivable, net decreased 3.9% to $18.86M from $19.63M at Dec 31, 2025.
• · Goodwill and intangible assets, net decreased 8.0% to $6.97M from $7.57M at Dec 31, 2025.
• · Digital assets increased 18.0% to $1.66M from $1.41M at Dec 31, 2025, with $1.1M in purchases during H1 2026.
• · Derivative liability decreased 62.6% to $0.48M from $1.29M at Dec 31, 2025.
• · Convertible notes payable (current + long-term) decreased 46.0% to $3.39M from $6.41M at Dec 31, 2025.
• · Lines of credit decreased 4.7% to $8.75M from $9.18M at Dec 31, 2025.
• · Treasury stock repurchases of $0.51M during Q2 2026 (2.65M shares).
• · Proceeds from sale of common stock totaled $2.94M in H1 2026.
• · Interest expense increased 78.0% to $1.03M in H1 2026 from $0.58M in H1 2025.
• · Non-cash interest expense increased 385.6% to $0.79M in H1 2026 from $0.16M in H1 2025.
• · Change in fair value of convertible notes was a loss of $2.14M in H1 2026 vs. a loss of $0.14M in H1 2025.
• · Gain/(Loss) on digital assets was a loss of $0.85M in H1 2026 (no comparable in H1 2025).
• · Revenue reversals of $0.63M in H1 2026 (none in H1 2025).
• · Weighted average basic shares outstanding increased 95.2% to 59.9M in Q2 2026 from 28.8M in Q2 2025.

18-08-2026

Cornerstone Building Brands reported a net loss of $170.8 million for Q2 FY26 (three months ended July 4, 2026), widening from a $60.0 million loss in the same quarter last year, driven by a 24.5% decline in gross profit and a $34.8 million impairment charge. Net sales edged up 1.1% to $1.44 billion, but selling, general and administrative expenses rose 1.2%, and operating income swung to a loss of $72.3 million from a $42.4 million profit. For the six-month period, net loss more than doubled to $363.3 million, and total equity turned negative at ($888.1 million) as of July 4, 2026.

• · Cash and cash equivalents remained nearly flat at $136.3M as of July 4, 2026, compared to $135.5M at Dec 31, 2025.
• · Accounts receivable increased 21.0% to $685.9M from $567.1M at Dec 31, 2025.
• · Inventories increased 6.5% to $794.3M from $745.5M at Dec 31, 2025.
• · Total assets decreased slightly to $6.18B from $6.21B at Dec 31, 2025.
• · Long-term debt rose to $5.25B from $4.97B at Dec 31, 2025, an increase of 5.6%.
• · Accounts payable surged 60.0% to $431.3M from $269.4M at Dec 31, 2025.
• · Net cash used in operating activities for the six months was $172.1M, compared to $132.2M in the prior year period.
• · Capital expenditures were $61.9M for the six months, down from $68.2M a year ago.
• · The company recorded a bargain purchase gain of $51.2M from an acquisition during the period.
• · Accumulated deficit widened to ($2.39B) from ($2.03B) at Dec 31, 2025.

18-08-2026

OMNIQ Corp. reported a net loss of $528,000 for Q2 2026, swinging from a net income of $2.055 million in Q2 2025, driven by a sharp increase in selling, general and administrative expenses to $2.839 million from $1.651 million. Revenue declined 5.5% to $7.375 million, while gross profit margin contracted to 20.6% from 25.4%. The company's accumulated deficit deepened to $126.4 million, and total stockholders' equity turned more negative to ($14.870 million), though cash and cash equivalents improved to $1.083 million from $679,000 at year-end 2025.

• · Inventory decreased to $3.073M from $3.409M at year-end 2025, with allowance for obsolescence increasing to $941K from $723K.
• · Goodwill decreased slightly to $3.304M from $3.336M.
• · Right of use lease asset increased to $2.369M from $1.656M.
• · Line of credit increased to $1.784M from $1.342M.
• · Notes payable – current portion decreased to $4.311M from $5.486M.
• · Other current liabilities decreased to $1.706M from $2.933M.
• · Operating cash flow from continuing operations was $877K for H1 2026, down from $6.072M in H1 2025.
• · Cash used in financing activities was $2.253M in H1 2026 vs $1.716M in H1 2025.
• · Weighted average basic shares outstanding increased to 15,140,705 from 10,712,930 due to equity raise.
• · Net loss per share (basic) was ($0.03) in Q2 2026 vs $0.19 in Q2 2025.
• · Management is evaluating operating expenses to reduce expenditures without negatively impacting operations.
• · Short-term liabilities decreased from $86.3M to roughly $27.7M per management commentary.

18-08-2026

IRONSTONE PROPERTIES, INC. reported a net loss of $87,766 for Q2 2026, widening from $81,608 in Q2 2025, and a six-month net loss of $175,822 compared to $157,995 in the prior year period. The company has no revenue-generating operations, with losses driven entirely by operating expenses and rising interest costs. Total assets declined slightly to $3.26M, while total liabilities increased to $3.83M, resulting in a negative stockholders' equity of $569,216.

• · The company has no revenue from operations; income lines (mark-to-market, realized gains, dividends) are all zero.
• · Stockholders' equity is negative at ($569,216) as of June 30, 2026, worsening from ($426,395) at December 31, 2025.
• · Note payable and accrued interest increased by $111,779 (3.5%) from $3,225,974 to $3,337,753.
• · Interest payable on line of credit increased by $13,506 (19.3%) from $69,850 to $83,356.
• · Cash paid for interest during the six months ended June 30, 2026 was $0, indicating interest is being accrued rather than paid.
• · The company issued $33,001 in stock options to officers and directors in both periods.
• · Net loss per share (basic and diluted) remained unchanged at ($0.03) for Q2 and ($0.06) for the six months.

18-08-2026

Taylor Devices, Inc. reported a 10% decline in net revenue to $41,650,000 for the fiscal year ended May 31, 2026, compared to $46,293,000 in the prior year. Gross profit fell 15% to $18,347,000, and net income decreased by $849,000. However, the company increased R&D spending by 75% to $776,000 and reduced SG&A expenses by 10% to $10,228,000, while net CIEB surged 61% to $10,597,000.

• · Gross margin declined from 46% to 44% of net revenue.
• · Inventory turnover slowed slightly from 2.7 to 2.6.
• · DSO increased from 32 days to 40 days.
• · Finished goods inventory dropped 28% to $189,000.
• · Maintenance and other inventory rose 9% to $1,206,000.

18-08-2026

Middleby Food Processing, Inc. (MFP) reported net sales of $245.4M for Q2 2026 (three months ended July 4, 2026), up 13.2% from $216.7M in Q2 2025, and $470.4M for the first half of 2026, up 22.1% from $385.2M in the prior-year period. However, net earnings fell sharply: Q2 net earnings dropped 62.9% to $10.8M from $29.1M, and first-half net earnings declined 39.2% to $25.1M from $41.3M, driven by a swing to net interest expense and a large swing in other expense/income. The company also made a $233.0M distribution to its parent during the quarter, significantly reducing Parent company net investment.

• · Gross profit for Q2 2026 was $86.7M vs $80.9M in Q2 2025, a 7.2% increase.
• · Selling, general and administrative expenses rose to $62.8M in Q2 2026 from $54.6M in Q2 2025, a 15.0% increase.
• · Restructuring expenses were $0.2M in Q2 2026 vs $0.0M in Q2 2025.
• · Provision for income taxes increased to $10.5M in Q2 2026 from $8.4M in Q2 2025, a 25.0% increase.
• · Foreign currency translation adjustments were a loss of $1.6M in Q2 2026 vs a gain of $5.9M in Q2 2025.
• · Comprehensive income for Q2 2026 was $9.2M, down 73.7% from $35.0M in Q2 2025.
• · Net transfers to Parent totaled $59.9M in the first half of 2026, compared to net transfers from Parent of $9.7M in the first half of 2025.
• · Accounts receivable, net decreased to $212.6M as of July 4, 2026 from $215.3M as of January 3, 2026.
• · Inventories, net increased to $207.1M from $193.6M.
• · Goodwill decreased slightly to $499.3M from $502.3M.
• · Other intangibles, net decreased to $165.9M from $173.3M.
• · Current maturities of long-term debt were $4.5M vs $4.8M.
• · Accounts payable decreased to $71.7M from $77.1M.
• · Accrued expenses increased to $223.3M from $217.2M.

18-08-2026

Envirotech Vehicles, Inc. (EVTV) reported a net loss of $10.6M for the six months ended June 30, 2026, an improvement from a $19.2M loss in the prior-year period, driven by a $10.1M goodwill impairment charge in 2025 that did not recur. Revenue grew 200% to $4.9M, but the company remained gross-profit negative at ($117K) and operating expenses surged 47% to $9.4M. Cash and cash equivalents fell 60% to $142K, while total assets more than tripled to $15.6M, largely due to $8.5M in construction in progress and a $9.3M increase in current debt.

• · The company's accumulated deficit grew to $123.2M as of June 30, 2026, from $112.6M at December 31, 2025.
• · Stockholders' deficit worsened to ($12.4M) from ($8.9M) at year-end 2025.
• · Net cash used in operating activities increased to $8.7M for the six months, compared to $5.4M in the prior-year period.
• · Capital expenditures unpaid at June 30, 2026 totaled $4.2M.
• · The company issued $10.5M in debentures during the six months, contributing to the surge in current debt.
• · Construction in progress of $8.5M was the largest component of property and equipment, up from $0 at year-end 2025.
• · The company's gross profit remained negative for the six-month period at ($117K), though improved from ($1.3M) a year ago.
• · Operating expenses excluding the goodwill impairment charge increased 47.5% to $9.4M from $6.4M in the prior-year period.

18-08-2026

Sypris Solutions reported a net loss of $3.1M for Q2 2026 (vs. $2.1M loss in Q2 2025) and a net loss of $7.2M for H1 2026 (vs. $2.9M loss in H1 2025). Revenue declined 3.5% YoY in Q2 to $30.3M and 7.8% YoY in H1 to $56.2M. Gross profit fell sharply to $2.0M in Q2 (from $2.6M) and to $2.8M in H1 (from $6.0M), while SG&A expenses rose 10.2% in Q2 and 17.8% in H1, driving a widening operating loss. Cash used in operations improved to $0.5M (from $4.4M), but the company ended the period with $5.9M in cash, down from $6.8M at year-end 2025.

• · Inventory net of reserves was $50.5M at July 5, 2026, down from $52.5M at year-end 2025.
• · Accounts receivable increased to $10.5M from $9.8M at year-end 2025.
• · Total liabilities rose to $93.5M from $90.0M at year-end 2025, driven by a new loan payable of $1.1M and an increase in other liabilities.
• · The company had a working capital line of credit of $0.5M outstanding, unchanged from year-end.
• · Depreciation and amortization for H1 2026 was $1.5M, up from $1.4M in H1 2025.
• · Stock-based compensation expense was $0.7M in H1 2026 vs. $0.6M in H1 2025.
• · Capital expenditures were $0.6M in H1 2026 vs. $0.2M in H1 2025.
• · The company had a net decrease in cash of $0.9M in H1 2026 vs. a $3.3M decrease in H1 2025.
• · No dividends were declared in either period.

18-08-2026

Greenwave Technology Solutions, Inc. reported a significant improvement in operating performance for the three and six months ended June 30, 2026. Revenue for the quarter surged 45.5% to $15.996M from $10.996M in the prior-year quarter, and gross profit nearly tripled to $6.060M from $2.113M. However, the company continued to post net losses, though the quarterly net loss narrowed to $3.241M from $4.918M a year earlier. Cash declined sharply to $654,987 from $935,763 at year-end 2025, and the company's accumulated deficit deepened to $525.656M, while total liabilities rose to $31.558M from $29.232M.

• · Operating expenses rose to $8.906M in Q2 2026 from $6.765M in Q2 2025, a 31.7% increase.
• · Interest expense and amortization of debt discount fell sharply to $393,311 in Q2 2026 from $1.336M in Q2 2025.
• · Net cash provided by operating activities was $948,134 in H1 2026, versus a use of $2.930M in H1 2025.
• · The company had no stock-based compensation in H1 2026, compared to $100,000 in H1 2025.
• · Non-convertible notes payable (current portion) increased to $5.457M from $1.798M at year-end 2025.
• · Due to related parties rose to $5.117M from $3.542M at December 31, 2025.
• · The company's weighted average basic shares outstanding increased to 829,631 in H1 2026 from 503,110 in H1 2025.
• · No proceeds from sale of common stock and warrants in H1 2026, versus $9.144M in H1 2025.